Literature DB >> 14689125

Delayed oedema in the pyramidal tracts remote from intracerebral missile path following gunshot injury.

R Thiex1, A Thron, E Uhl.   

Abstract

A 60-year-old man developed a severe left hemiparesis and central facial palsy, accompanied by somnolence and dysarthria 9 days after a gunshot wound to the right temporal region, from which he slowly recovered over 3 months. MRI disclosed bilateral oedema of the pyramidal tracts. This was interpreted as a consequence of the impact of the pressure wave caused by the bullet, after excluding an infectious or vascular cause.

Entities:  

Mesh:

Year:  2003        PMID: 14689125     DOI: 10.1007/s00234-003-1141-7

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  6 in total

1.  Secondary damage in wounding due to pressure changes accompanying the passage of high velocity missiles.

Authors:  E N HARVEY; I M KORR
Journal:  Surgery       Date:  1947-02       Impact factor: 3.982

2.  Computerized tomographic scan and gunshot wounds of the head: indications and radiographic findings.

Authors:  P R Cooper; K Maravilla; J Cone
Journal:  Neurosurgery       Date:  1979-05       Impact factor: 4.654

3.  [Computed tomographic findings and controls in craniocerebral gunshot wounds].

Authors:  B U Seidel; H Vogelsang; M Galanski
Journal:  Neurochirurgia (Stuttg)       Date:  1983-11

4.  The wound profile: a visual method for quantifying gunshot wound components.

Authors:  M L Fackler; J A Malinowski
Journal:  J Trauma       Date:  1985-06

Review 5.  Penetrating gunshots to the head and lack of immediate incapacitation. I. Wound ballistics and mechanisms of incapacitation.

Authors:  B Karger
Journal:  Int J Legal Med       Date:  1995       Impact factor: 2.686

6.  CT analysis of missile head injury.

Authors:  N Besenski; D Jadro-Santel; F Jelavić-Koić; D Pavić; D Mikulić; K Glavina; J Masković
Journal:  Neuroradiology       Date:  1995-04       Impact factor: 2.804

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.